Antitumor vaccine effect of irradiated murine neuroblastoma cells producing interleukin-2 or granulocyte macrophage-colony stimulating factor.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  International Journal of Oncology

• Publication date

  1998-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJO.13.1.73PMID 9625805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antitumor effect induced by granulocyte/macrophage-colony-stimulating factor gene-modified tumor vaccination: Comparison of adenovirus- and retrovirus-mediated genetic transduction

  2005cited by this paper
• Impaired tumorigenicity of IL-4-producing murine neuroblastoma cells in immunodeficient nude mice.

  1998cited by this paper
• Impaired tumorigenicity and decreased liver metastasis of murine neuroblastoma cells engineered to secrete interleukin-2 or granulocyte macrophage colony-stimulating factor.

  1998cited by this paper
• Gene-based strategies for the immunotherapy of cancer

  1997cited by this paper
• Gene Therapy for Metastatic Brain Tumors by Vaccination with Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Tumor Cells

  1997cited by this paper
• Drug resistance to ganciclovir observed in suicide gene therapy is due to the loss of integrated herpes simplex virus-thymidine kinase gene.

  1997cited by this paper
• Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines.

  1996cited by this paper
• The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanoma.

  1996cited by this paper
• Study of irradiation effects on cytokine secretion from retrovirally-transduced tumor cells: a model for tumor vaccination.

  1996cited by this paper
• Murine colon carcinoma cells engineered to produce human interleukin‐2 induce tumor‐specific anti‐tumor response

  1996cited by this paper
• Cancer vaccines: the interleukin 2 dosage effect.

  1995cited by this paper
• Interleukin-2 gene transfer into murine neuroblastoma decreases tumorigenicity and enhances systemic immunity causing regression of preestablished retroperitoneal tumors.

  1994cited by this paper
• Experimental and Clinical Studies of Cytokine Gene-Modified Tumor Cells

  1994cited by this paper
• Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.

  1993cited by this paper
• Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells.

  1992cited by this paper
• Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells.

  1992cited by this paper
• Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

  1991cited by this paper
• How frequent is spontaneous remission of neuroblastomas? Implications for screening.

  1990cited by this paper
• Improved retroviral vectors for gene transfer and expression.

  1989cited by this paper
• Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity.

  1989cited by this paper
• Retroviral expression of the human IL‐2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity.

  1987cited by this paper
• Structure of the chromosomal gene for granulocyte‐macrophage colony stimulating factor: comparison of the mouse and human genes.

  1985cited by this paper

• Drug delivery to osteoclast receptor targets

  2009cites this paper
• Effects of tetrandrine plus radiation on neuroblastoma cells.

  2009cites this paper
• Molecular regulation of osteoclast activity

  2007influential citation
• Superior Protective and Therapeutic Effects of IL-12 and IL-18 Gene-Transduced Dendritic Neuroblastoma Fusion Cells on Liver Metastasis of Murine Neuroblastoma1

  2006cites this paper
• Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice.

  2004cites this paper
• CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.

  2003cites this paper
• Malignant abdominal masses in children: quick guide to evaluation and diagnosis.

  2002cites this paper
• DNA-binding of drugs used in medicinal therapies.

  2002cites this paper
• Effects of irradiated tumor vaccine and continuous localized infusion of granulocyte-macrophage colony-stimulating factor on neuroblastomas in mice.

  2002cites this paper
• Antitumor effects of the combination therapy with TNF-α gene–modified tumor cells and interleukin 12 in a melanoma model in mice

  2000cites this paper
• Granulocyte-macrophage colony-stimulating factor gene-modified vaccines for immunotherapy of cancer.

  1999cites this paper
• Induced immunity by expression of interleukin-2 or GM-CSF gene in murine neuroblastoma cells can generate antitumor response to established tumors

  1999cites this paper
• Granulocyte-macrophage colony-stimulating factor-producing tumour vaccines.

  1999cites this paper